Patricia Heyn
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Equity | 9 | 2025 | 139 | 3.700 |
Why?
| | Cognitive Dysfunction | 9 | 2025 | 479 | 2.650 |
Why?
| | Cerebral Palsy | 6 | 2022 | 146 | 1.790 |
Why?
| | Terminology as Topic | 3 | 2025 | 253 | 1.730 |
Why?
| | Meta-Analysis as Topic | 3 | 2025 | 173 | 1.510 |
Why?
| | Cognition Disorders | 7 | 2016 | 547 | 1.500 |
Why?
| | Exercise | 8 | 2025 | 2206 | 1.250 |
Why?
| | Alzheimer Disease | 6 | 2024 | 640 | 1.200 |
Why?
| | Racism | 4 | 2025 | 147 | 1.130 |
Why?
| | Self-Help Devices | 3 | 2014 | 24 | 1.020 |
Why?
| | Research Personnel | 2 | 2026 | 189 | 1.000 |
Why?
| | Exercise Therapy | 4 | 2025 | 486 | 0.980 |
Why?
| | Rehabilitation Research | 1 | 2026 | 8 | 0.950 |
Why?
| | Activities of Daily Living | 4 | 2021 | 438 | 0.940 |
Why?
| | Parkinson Disease | 4 | 2026 | 614 | 0.850 |
Why?
| | Physical Therapy Modalities | 2 | 2020 | 341 | 0.850 |
Why?
| | Geriatrics | 5 | 2025 | 96 | 0.850 |
Why?
| | Cognition | 6 | 2025 | 1286 | 0.810 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 2 | 2026 | 37 | 0.790 |
Why?
| | Integrative Medicine | 2 | 2022 | 17 | 0.790 |
Why?
| | Dementia | 6 | 2023 | 322 | 0.780 |
Why?
| | Aging | 6 | 2026 | 1983 | 0.780 |
Why?
| | Video Games | 2 | 2021 | 25 | 0.770 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2021 | 155 | 0.760 |
Why?
| | Brain Injuries, Traumatic | 4 | 2026 | 459 | 0.750 |
Why?
| | Language | 1 | 2026 | 313 | 0.740 |
Why?
| | Humans | 75 | 2026 | 145625 | 0.710 |
Why?
| | Patient Participation | 1 | 2026 | 454 | 0.710 |
Why?
| | Social Determinants of Health | 3 | 2024 | 315 | 0.690 |
Why?
| | Intellectual Disability | 1 | 2023 | 178 | 0.690 |
Why?
| | Elder Nutritional Physiological Phenomena | 1 | 2021 | 1 | 0.690 |
Why?
| | Nutrition Therapy | 1 | 2021 | 37 | 0.660 |
Why?
| | Virtual Reality | 1 | 2022 | 82 | 0.660 |
Why?
| | Complementary Therapies | 2 | 2020 | 93 | 0.650 |
Why?
| | Artificial Intelligence | 1 | 2026 | 385 | 0.650 |
Why?
| | Internet | 1 | 2025 | 656 | 0.640 |
Why?
| | Developmental Disabilities | 1 | 2023 | 280 | 0.630 |
Why?
| | Accidental Falls | 2 | 2021 | 226 | 0.630 |
Why?
| | Home Care Services | 1 | 2023 | 290 | 0.580 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2019 | 57 | 0.570 |
Why?
| | Review Literature as Topic | 1 | 2019 | 53 | 0.570 |
Why?
| | Dwarfism | 1 | 2018 | 15 | 0.570 |
Why?
| | Polycomb-Group Proteins | 1 | 2018 | 36 | 0.560 |
Why?
| | Gain of Function Mutation | 1 | 2018 | 35 | 0.560 |
Why?
| | DNA Methylation | 2 | 2026 | 721 | 0.550 |
Why?
| | Editorial Policies | 1 | 2019 | 45 | 0.550 |
Why?
| | Motor Skills | 1 | 2019 | 102 | 0.530 |
Why?
| | Microcephaly | 1 | 2018 | 105 | 0.520 |
Why?
| | Brain Diseases | 1 | 2019 | 157 | 0.520 |
Why?
| | Cell Nucleolus | 1 | 2016 | 21 | 0.490 |
Why?
| | Coiled Bodies | 1 | 2016 | 9 | 0.490 |
Why?
| | Femur Head Necrosis | 1 | 2016 | 15 | 0.470 |
Why?
| | Aged | 19 | 2026 | 26251 | 0.460 |
Why?
| | Physical and Rehabilitation Medicine | 1 | 2016 | 30 | 0.460 |
Why?
| | Hip Dislocation, Congenital | 1 | 2016 | 41 | 0.460 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1581 | 0.430 |
Why?
| | Walking | 2 | 2022 | 544 | 0.430 |
Why?
| | Metabolic Syndrome | 1 | 2019 | 364 | 0.430 |
Why?
| | Blood Pressure | 2 | 2021 | 1761 | 0.430 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2018 | 304 | 0.430 |
Why?
| | Histones | 2 | 2018 | 670 | 0.430 |
Why?
| | Neurodegenerative Diseases | 1 | 2017 | 147 | 0.420 |
Why?
| | Transcriptional Activation | 1 | 2016 | 368 | 0.420 |
Why?
| | Diet | 2 | 2020 | 1271 | 0.420 |
Why?
| | Hip Joint | 1 | 2016 | 172 | 0.420 |
Why?
| | Pain Management | 1 | 2018 | 413 | 0.420 |
Why?
| | Chronic Pain | 1 | 2018 | 302 | 0.390 |
Why?
| | Life Style | 1 | 2016 | 495 | 0.390 |
Why?
| | Orthopedic Procedures | 1 | 2016 | 252 | 0.380 |
Why?
| | Caregivers | 2 | 2023 | 1079 | 0.360 |
Why?
| | Minority Groups | 2 | 2025 | 285 | 0.360 |
Why?
| | Zebrafish | 1 | 2016 | 533 | 0.350 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2025 | 1754 | 0.350 |
Why?
| | Gene Library | 1 | 2012 | 121 | 0.340 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 1212 | 0.340 |
Why?
| | Adaptation, Psychological | 1 | 2017 | 718 | 0.340 |
Why?
| | Mobile Applications | 1 | 2014 | 193 | 0.340 |
Why?
| | Brain | 6 | 2024 | 2981 | 0.320 |
Why?
| | Scoliosis | 2 | 2024 | 230 | 0.310 |
Why?
| | Reading | 1 | 2010 | 132 | 0.290 |
Why?
| | Cardiovascular Diseases | 2 | 2019 | 2218 | 0.290 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2012 | 538 | 0.270 |
Why?
| | Stress, Psychological | 1 | 2017 | 1169 | 0.270 |
Why?
| | Mental Health | 3 | 2023 | 771 | 0.270 |
Why?
| | Employment | 1 | 2010 | 180 | 0.260 |
Why?
| | Biomedical Research | 2 | 2025 | 724 | 0.250 |
Why?
| | United States | 9 | 2025 | 16041 | 0.240 |
Why?
| | Physical Endurance | 1 | 2008 | 278 | 0.240 |
Why?
| | Progeria | 1 | 2026 | 6 | 0.240 |
Why?
| | Fatigue | 4 | 2023 | 362 | 0.230 |
Why?
| | Resistance Training | 1 | 2008 | 185 | 0.220 |
Why?
| | Telerehabilitation | 1 | 2026 | 49 | 0.220 |
Why?
| | DNA | 1 | 2012 | 1418 | 0.220 |
Why?
| | Aged, 80 and over | 6 | 2021 | 8351 | 0.210 |
Why?
| | Male | 16 | 2025 | 73014 | 0.210 |
Why?
| | Female | 17 | 2026 | 79080 | 0.200 |
Why?
| | Health Status Disparities | 2 | 2024 | 321 | 0.200 |
Why?
| | Oral Health | 1 | 2025 | 139 | 0.190 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 29 | 0.190 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 147 | 0.190 |
Why?
| | Patient Care Team | 2 | 2020 | 700 | 0.190 |
Why?
| | Attention | 1 | 2026 | 459 | 0.180 |
Why?
| | Spinal Cord Injuries | 2 | 2017 | 238 | 0.180 |
Why?
| | Geriatricians | 1 | 2022 | 1 | 0.180 |
Why?
| | Acupuncture Therapy | 1 | 2022 | 20 | 0.180 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5875 | 0.170 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2026 | 421 | 0.170 |
Why?
| | Intracranial Pressure | 1 | 2022 | 64 | 0.170 |
Why?
| | Healthcare Disparities | 2 | 2025 | 728 | 0.170 |
Why?
| | Vitamin D Deficiency | 1 | 2024 | 188 | 0.170 |
Why?
| | Risk Assessment | 3 | 2022 | 3678 | 0.170 |
Why?
| | Young Adult | 5 | 2022 | 14240 | 0.160 |
Why?
| | Neuropsychological Tests | 2 | 2021 | 1136 | 0.160 |
Why?
| | Hearing Disorders | 1 | 2020 | 7 | 0.160 |
Why?
| | Interviews as Topic | 1 | 2024 | 926 | 0.160 |
Why?
| | Shoes | 1 | 2020 | 19 | 0.150 |
Why?
| | Hydroxyethylrutoside | 1 | 2019 | 1 | 0.150 |
Why?
| | Rehabilitation Centers | 1 | 2020 | 39 | 0.150 |
Why?
| | Social Participation | 1 | 2020 | 27 | 0.150 |
Why?
| | Climate Change | 1 | 2022 | 184 | 0.150 |
Why?
| | Waist-Hip Ratio | 1 | 2019 | 37 | 0.140 |
Why?
| | Nutritive Value | 1 | 2019 | 41 | 0.140 |
Why?
| | DNA Modification Methylases | 1 | 2018 | 19 | 0.140 |
Why?
| | Cooking | 1 | 2019 | 62 | 0.140 |
Why?
| | Vision Disorders | 1 | 2020 | 178 | 0.140 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2018 | 90 | 0.140 |
Why?
| | Waist Circumference | 1 | 2019 | 142 | 0.140 |
Why?
| | Environment | 1 | 2020 | 295 | 0.130 |
Why?
| | Calcium Channel Blockers | 1 | 2019 | 165 | 0.130 |
Why?
| | Antifibrinolytic Agents | 1 | 2019 | 68 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.130 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2018 | 98 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 266 | 0.130 |
Why?
| | Longitudinal Studies | 2 | 2025 | 3005 | 0.130 |
Why?
| | Ribonucleoprotein, U7 Small Nuclear | 1 | 2016 | 2 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2019 | 267 | 0.120 |
Why?
| | HeLa Cells | 1 | 2018 | 635 | 0.120 |
Why?
| | Muscle Strength | 1 | 2020 | 332 | 0.120 |
Why?
| | Zygote | 1 | 2016 | 14 | 0.120 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2016 | 24 | 0.120 |
Why?
| | Risk Factors | 4 | 2023 | 10840 | 0.120 |
Why?
| | Health Personnel | 1 | 2023 | 750 | 0.120 |
Why?
| | RNA, Small Nuclear | 1 | 2016 | 40 | 0.120 |
Why?
| | DNA, Ribosomal | 1 | 2016 | 83 | 0.120 |
Why?
| | Spliceosomes | 1 | 2016 | 54 | 0.120 |
Why?
| | Brain-Computer Interfaces | 1 | 2016 | 13 | 0.120 |
Why?
| | Health Promotion | 1 | 2023 | 786 | 0.120 |
Why?
| | Quality of Life | 2 | 2021 | 3187 | 0.120 |
Why?
| | Age Factors | 2 | 2016 | 3321 | 0.120 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2016 | 130 | 0.120 |
Why?
| | Embryonic Development | 1 | 2016 | 124 | 0.110 |
Why?
| | Adolescent | 6 | 2024 | 22451 | 0.110 |
Why?
| | Treatment Outcome | 3 | 2019 | 11744 | 0.110 |
Why?
| | Social Support | 1 | 2020 | 644 | 0.110 |
Why?
| | Pressure Ulcer | 1 | 2015 | 41 | 0.110 |
Why?
| | Pilot Projects | 1 | 2021 | 1878 | 0.110 |
Why?
| | RNA Splicing | 1 | 2016 | 287 | 0.110 |
Why?
| | Adult | 5 | 2022 | 40821 | 0.100 |
Why?
| | Self Report | 1 | 2019 | 869 | 0.100 |
Why?
| | National Institute on Aging (U.S.) | 2 | 2025 | 4 | 0.100 |
Why?
| | Government Programs | 1 | 2014 | 27 | 0.100 |
Why?
| | Sternoclavicular Joint | 1 | 2014 | 13 | 0.100 |
Why?
| | Engineering | 1 | 2014 | 31 | 0.100 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 6050 | 0.100 |
Why?
| | Joint Dislocations | 1 | 2014 | 60 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2131 | 0.100 |
Why?
| | Odds Ratio | 1 | 2016 | 1070 | 0.100 |
Why?
| | Anticoagulants | 1 | 2019 | 743 | 0.100 |
Why?
| | Brain Mapping | 1 | 2016 | 540 | 0.100 |
Why?
| | Prevalence | 2 | 2019 | 2852 | 0.090 |
Why?
| | Hypertension | 1 | 2021 | 1270 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4329 | 0.090 |
Why?
| | Sleep | 1 | 2020 | 896 | 0.090 |
Why?
| | Protein Binding | 1 | 2018 | 2239 | 0.090 |
Why?
| | Phenotype | 1 | 2021 | 3186 | 0.090 |
Why?
| | Time Factors | 2 | 2016 | 7079 | 0.090 |
Why?
| | Uracil | 1 | 2012 | 37 | 0.090 |
Why?
| | Recovery of Function | 1 | 2016 | 721 | 0.090 |
Why?
| | Clinical Competence | 1 | 2020 | 1261 | 0.090 |
Why?
| | Cells, Cultured | 1 | 2018 | 4112 | 0.080 |
Why?
| | Articulation Disorders | 1 | 2010 | 7 | 0.080 |
Why?
| | Research | 1 | 2014 | 421 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3538 | 0.080 |
Why?
| | Middle Aged | 4 | 2025 | 36359 | 0.080 |
Why?
| | Animals | 5 | 2026 | 38030 | 0.080 |
Why?
| | Models, Biological | 1 | 2016 | 1758 | 0.070 |
Why?
| | DNA Damage | 1 | 2012 | 437 | 0.070 |
Why?
| | Comprehension | 1 | 2010 | 175 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2014 | 431 | 0.070 |
Why?
| | Research Design | 2 | 2024 | 1139 | 0.070 |
Why?
| | Child Welfare | 1 | 2010 | 228 | 0.070 |
Why?
| | Disability Evaluation | 1 | 2010 | 297 | 0.070 |
Why?
| | Stroke | 1 | 2017 | 1283 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2944 | 0.060 |
Why?
| | Amantadine | 1 | 2026 | 8 | 0.060 |
Why?
| | Mice | 2 | 2026 | 18266 | 0.060 |
Why?
| | Primary Health Care | 1 | 2017 | 1768 | 0.060 |
Why?
| | Methylphenidate | 1 | 2026 | 48 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2910 | 0.060 |
Why?
| | Syndrome | 1 | 2026 | 377 | 0.060 |
Why?
| | Mass Screening | 2 | 2022 | 1300 | 0.060 |
Why?
| | Qualitative Research | 2 | 2024 | 1720 | 0.050 |
Why?
| | Child | 4 | 2024 | 22638 | 0.050 |
Why?
| | Logic | 1 | 2024 | 7 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2024 | 3633 | 0.050 |
Why?
| | India | 1 | 2025 | 213 | 0.050 |
Why?
| | Central Nervous System Stimulants | 1 | 2026 | 183 | 0.050 |
Why?
| | Cell Lineage | 1 | 2026 | 375 | 0.050 |
Why?
| | Eye Diseases | 1 | 2005 | 98 | 0.050 |
Why?
| | Academies and Institutes | 1 | 2024 | 60 | 0.050 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2023 | 27 | 0.050 |
Why?
| | Thioredoxins | 1 | 2023 | 30 | 0.050 |
Why?
| | Sampling Studies | 1 | 2003 | 97 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2006 | 359 | 0.050 |
Why?
| | Rural Health | 1 | 2023 | 86 | 0.050 |
Why?
| | Head | 1 | 2024 | 125 | 0.050 |
Why?
| | Braces | 1 | 2022 | 30 | 0.040 |
Why?
| | Stem Cells | 1 | 2026 | 612 | 0.040 |
Why?
| | Walking Speed | 1 | 2022 | 53 | 0.040 |
Why?
| | Nursing Homes | 1 | 2003 | 171 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2026 | 705 | 0.040 |
Why?
| | Immunoglobulin A | 1 | 2022 | 205 | 0.040 |
Why?
| | Vision Tests | 1 | 2020 | 22 | 0.040 |
Why?
| | Affect | 1 | 2003 | 317 | 0.040 |
Why?
| | Vitamin D | 1 | 2024 | 402 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 610 | 0.040 |
Why?
| | Hearing | 1 | 2021 | 102 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2024 | 353 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2022 | 221 | 0.040 |
Why?
| | Hearing Tests | 1 | 2020 | 41 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2024 | 525 | 0.040 |
Why?
| | Gait | 1 | 2022 | 316 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2010 | 6449 | 0.030 |
Why?
| | Health Behavior | 1 | 2004 | 801 | 0.030 |
Why?
| | Rural Population | 1 | 2023 | 673 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 502 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2006 | 1247 | 0.030 |
Why?
| | Hypesthesia | 1 | 2017 | 21 | 0.030 |
Why?
| | Antihypertensive Agents | 1 | 2021 | 519 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2024 | 1526 | 0.030 |
Why?
| | Muscle Weakness | 1 | 2017 | 92 | 0.030 |
Why?
| | Executive Function | 1 | 2021 | 461 | 0.030 |
Why?
| | Infant | 1 | 2010 | 10093 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2228 | 0.030 |
Why?
| | Symptom Assessment | 1 | 2017 | 137 | 0.030 |
Why?
| | Memory Disorders | 1 | 2017 | 197 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2017 | 249 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1728 | 0.030 |
Why?
| | Child, Preschool | 1 | 2010 | 11888 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2857 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 1074 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2017 | 219 | 0.030 |
Why?
| | Mutation | 1 | 2026 | 4082 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2024 | 2455 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2021 | 847 | 0.030 |
Why?
| | Manipulation, Orthopedic | 1 | 2014 | 8 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 54 | 0.030 |
Why?
| | Clavicle | 1 | 2014 | 38 | 0.020 |
Why?
| | Emotions | 1 | 2017 | 555 | 0.020 |
Why?
| | Fracture Fixation, Internal | 1 | 2014 | 214 | 0.020 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2005 | 80 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17291 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2014 | 2962 | 0.010 |
Why?
| | Logistic Models | 1 | 2005 | 2112 | 0.010 |
Why?
|
|
Heyn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|